Conclusions: This survey suggested that CTD have a major impact on FP and family size, possibly mediated by the increased rate of miscarriages as compared to CA. Concerns about reproductive issues could be positively overcome by adequate counselling. Rheumatologists should implement the discussion about FP and the compatibility of drugs with pregnancy in the management of young women with RD Background: Medical Applications have the potential to support physicians and patients to document the course of the disease and optimize therapies. We describe the linkage and integration of patient reported outcomes (PROs) into existing medical office software and rheumatologic documentation systems by means of the digital applications RheumaLive and AxSpALive. RheumaLive is certified as medical product class I, and certification for AxSpALive is in preparation. Methods: RheumaLive and AxSpALive are applications that can be downloaded free of charge from the common app-stores (Android, Apple) and installed on mobile devices (smartphones, tablets). A freeware version for PCs is also available (Windows-und Mac OS X-Version). A diary functionality allows to document the medication uptake (partially filed, memory-functionality for medication uptake available), validated scores like VAS, SJC, morning stiffness, FFBh (comparable to HAQ), BASDAI, RADAI, etc. and days of sick leave (+/-related to the rheumatic disease). All App-versions are password-protected, which is provided by the treating rheumatologist (relationship patient-physician). The patient reported outcomes are stored locally on the respective device. For the subsequent visit, they can be printed or sent encrypted to the treating physician via internet in a prespecified interval. A specific software allows to integrate the data into the existing medical office software. In daily practise, data entered by patients into RheumaLive can be screened and compared with collected clinical data and laboratory measures, because of it's certification as medical product. In case of an increasing disease activity the patient can be rapidly contacted and medication can be modified, if necessary. Regular F2F-appointments remain integral part of the medical care, even in case of good controlled disease activity. But in case of F2F-appointments, PROs can be delivered by patients, saving time and resources. The PROs can be made available to rheumatologic documentation systems like RheumaDok via predefined interfaces. Results: In a first pilot phase 54 patients in 4 rheumatologic specialised practices were documented. In the next phase the number of patients and participating practices/centres shall be increased. Further studies are necessary to show if the integration of PROs which are collected via electronical application can lead to an improvement of rheumatologic diseases.
AB1101 QUALITY OF LIFE AND WORK IN PATIENTS WITH ANKYLOSING

SPONDYLITIS OF WORKING AGE
4 Epidemiology, University of Medicine and Pharmacy, Tg.Mures, Romania Background: The assessment of the quality of life is a current research issue in patients with ankylosis spondylitis 1,2 . The tools for assessing the life quality, come to complete the other methods of investigation, which assess in a subjective manner the negative impact of the disease on daily activities. Objectives: The purpose of this study is to define the functional ability, the disease activity, to investigate the correlation between work and quality of life, and the impact of the quality of life in patients with AS. BASFI=4,88±2,61SD; EQ-5D=5,71±0,20SD; EQ-VAS=64,26±18,938D; HAQ=0,747±0,51SD; SFphysical summary=33,53±8,33SD; SF-emotional summary=47,57±10,03SD; ASQOL=6,94±2,68SD. We found a positive correlation between the disease onset and retiring age p<0,0001, r=0,731a nd a negative significant correlation between BASFI and SFphysical summary (p<0,0001, r=-0,798), ASQOL and SF-emotional summary, p<0,0001, r=-0,595).
Conclusions:
The results showed the invalidant potential of the AS, with major impact upon the quality of life. Background: Road traffic accidents (RTAs) are the second leading injury health burden and cause of death in Europe, after falls (1). A significant but as yet unreported proportion of such burden is potentially due to low bone mineral density (BMD), especially among older people, through its relationship with fractures. Objectives: To measure the percentage of deaths, disability-adjusted life years (DALYs) and years lived with disability (YLDs) due to RTA in people aged 50 years and above attributable to low BMD in the European population for the year 2015. Methods: The estimates followed the Counterfactual Risk Assessment Methodology used in the GBD study (1). Systematic review was performed seeking population-based studies with femoral neck BMD (FNBMD) measured by Dual-XRay-Absorptiometry in people 50 years and over. Age-and sex-specific levels of mean +/-SD FNBMD (g/cm 2 ) were extracted from eligible studies, and this was used as the exposure variable. The age and sex-specific 99th percentile from nonHispanic whites in National Health and Nutrition Examination Survey (NHANES) 2009-2010 was used as theoretical minimum risk factor exposure distribution, to estimate the potential impact fraction (PIF) of FNBMD for fractures. Relative risks of FNBMD for fractures were obtained from a previous meta-analysis (2). Attributable deaths due to RTA-related fractures were obtained through coded hospital data. Disability levels were established by applying disability weights to each type of fracture. Then, PIFs were applied to obtain attributable deaths and disability due to low BMD. Results: In the European population aged 50-69 and 70 years and above, 10.8% (95% CI: 8.9-12.4%) and 30.9% (29.1-32.4%) of RTA-related deaths, respectively, were attributable to low BMD. In the age group 50-69 this was the second most important risk factor following alcohol use and in those 70 years and above became the most important risk factor, with double the weight of alcohol use. This represents 2,537 and 5,460 absolute deaths in those aged 50-69 and 70 years and above, respectively. The percentage of health burden and disability caused by RTAs attributable to low BMD grew steadily from the ages of 50 and onwards.
Conclusions: This data shows the non-previously reported important role of low BMD as a preventable risk factor for European RTAs' health burden in population 50 years and over, which requires urgent attention.
